FibroBiologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	13.99	9.16	2.27	0.41	-
Cash & Short-Term Investments	13.99	9.16	2.27	0.41	-
Cash Growth	52.63%	304.37%	456.76%	-	-
Receivables	-	-	0.3	-	-
Prepaid Expenses	0.23	0.04	0.03	0.04	-
Other Current Assets	0.02	0.02	0.03	0.02	-
Total Current Assets	14.23	9.22	2.63	0.47	-
Property, Plant & Equipment	2.22	2.61	2.2	-	-
Total Assets	16.45	11.82	4.82	0.47	-
Accounts Payable	2.7	1.44	0.76	0.23	-
Short-Term Debt	9.17	-	5.45	1.53	-
Current Portion of Leases	0.4	0.36	0.33	-	-
Other Current Liabilities	0.46	7.38	0.54	-	-
Total Current Liabilities	12.73	9.18	7.07	1.76	-
Long-Term Leases	0.98	1.39	1.75	-	-
Total Liabilities	13.71	10.57	8.82	1.76	-
Common Stock	-	0	0	-	1.17
Additional Paid-In Capital	38.25	25.61	2.41	-	-
Retained Earnings	-35.52	-24.36	-7.87	-2.75	-1.17
Comprehensive Income & Other	-	-	1.46	1.46	-
Shareholders' Equity	2.74	1.25	-4	-1.29	-
Total Liabilities & Equity	16.45	11.82	4.82	0.47	-
Total Debt	10.55	1.75	7.52	1.53	-
Net Cash (Debt)	3.43	7.42	-5.26	-1.12	-
Net Cash Growth	-53.72%	-	-	-	-
Net Cash Per Share	0.10	0.26	-0.19	-0.13	-
Filing Date Shares Outstanding	37.74	32.49	28.23	40.73	8.75
Total Common Shares Outstanding	35.09	28.23	28.23	40.73	8.75
Working Capital	1.5	0.03	-4.45	-1.29	-
Book Value Per Share	0.08	0.04	-0.14	-0.03	-
Tangible Book Value	2.74	1.25	-4	-1.29	-
Tangible Book Value Per Share	0.08	0.04	-0.14	-0.03	-
Machinery	1.03	0.84	-	-	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q